Ocugen Inc (OCGN)
1.00
+0.04
(+4.37%)
USD |
NASDAQ |
Nov 14, 16:00
1.02
+0.02
(+2.00%)
After-Hours: 04:41
Ocugen Cash and Short Term Investments (Quarterly): 38.70M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 38.70M |
| June 30, 2024 | 15.70M |
| March 31, 2024 | 26.38M |
| December 31, 2023 | 39.46M |
| September 30, 2023 | 53.48M |
| June 30, 2023 | 70.58M |
| March 31, 2023 | 76.72M |
| December 31, 2022 | 90.93M |
| September 30, 2022 | 101.60M |
| June 30, 2022 | 115.00M |
| March 31, 2022 | 129.77M |
| December 31, 2021 | 94.96M |
| September 30, 2021 | 107.35M |
| June 30, 2021 | 115.64M |
| March 31, 2021 | 44.79M |
| December 31, 2020 | 24.04M |
| September 30, 2020 | 19.11M |
| June 30, 2020 | 14.97M |
| March 31, 2020 | 3.193M |
| December 31, 2019 | 7.444M |
| September 30, 2019 | 15.30M |
| June 30, 2019 | 2.786M |
| Date | Value |
|---|---|
| March 31, 2019 | 7.376M |
| December 31, 2018 | 15.54M |
| September 30, 2018 | 5.192M |
| June 30, 2018 | 8.772M |
| March 31, 2018 | 15.51M |
| December 31, 2017 | 7.981M |
| September 30, 2017 | 12.62M |
| June 30, 2017 | 18.54M |
| March 31, 2017 | 24.37M |
| December 31, 2016 | 31.91M |
| September 30, 2016 | 37.99M |
| June 30, 2016 | 15.93M |
| March 31, 2016 | 22.90M |
| December 31, 2015 | 30.92M |
| September 30, 2015 | 37.72M |
| June 30, 2015 | 45.22M |
| March 31, 2015 | 53.18M |
| December 31, 2014 | 58.53M |
| September 30, 2014 | 4.258M |
| June 30, 2014 | 7.776M |
| December 31, 2013 | 8.734M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
3.193M
Minimum
Mar 2020
129.77M
Maximum
Mar 2022
59.49M
Average
49.13M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Cytokinetics Inc | 1.012B |
| Scholar Rock Holding Corp | 190.49M |
| Mirum Pharmaceuticals Inc | 278.37M |
| SpringWorks Therapeutics Inc | 383.88M |
| NeuroBo Pharmaceuticals Inc | 21.67M |